Indication
Hepatitis C Virus
3 clinical trials
6 products
Clinical trial
A Multicenter, Single-Arm Prospective Study to Evaluate Safety and Efficacy of GLE/PIB 8-Week Treatment in Adults and Adolescents With Acute Hepatitis C Virus (HCV) InfectionStatus: Active (not recruiting), Estimated PCD: 2024-09-16
Product
Glecaprevir + PibrentasvirClinical trial
An Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionStatus: Completed, Estimated PCD: 2020-05-21
Clinical trial
Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment: A Pilot ProjectStatus: Active (not recruiting), Estimated PCD: 2023-10-01
Product
ParitaprevirProduct
RitonavirProduct
DasabuvirProduct
OmbitasvirProduct
Ribavirin